secwatch.observer — SEC 8-K summary
======================================

Issuer:     NextPlat Corp (NXPL)
CIK:        0001058307
Form:       8-K
Filed at:   2026-10-06T20:17:02+00:00
Accession:  0001437749-26-032200
Event type: m_and_a
Sentiment:  positive
Materiality: 0.45
Item codes: 8.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

NextPlat closes $1.49M cash purchase of Pensacola-area pharmacy with ~$5.6M FY2025 sales
--------------------------------------------------------------------------------

- Total cash consideration of $1,485,439 for the independent pharmacy and its inventory; the Pharmacy generated approximately $5.6 million in sales for the year ended December 31, 2025.
- NextPlat said the Pharmacy was profitable, held positive working capital and a debt-free balance sheet, and is expected to add to the PharmcoRx healthcare segment in Q4 2026.
- PharmcoRx now operates five pharmacies across northern, central and southern Florida; the deal adds access to the Pensacola market and panhandle region.
- CEO David Phipps said the company is 'actively exploring additional opportunities' to acquire established, profitable community pharmacy operators.
- Planned rollout of higher-margin contracted services at the site: 340B, long-term care and senior living programs, which the company says are largely unavailable in the region.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1058307/000143774926032200/0001437749-26-032200-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1058307/000143774926032200/nxpl20261006_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-032200

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer